The recent FDA approval of teclistamab (Tecvayli) and daratumumab and hyaluronidase-fihj (Darzelex Faspro) marks a major ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.

Mind and Body Strategies for Success focuses on a familiar challenge in veterinary medicine: maintaining proper nutrition ...

SEATTLE – February 17, 2026 – Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein-Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is ...

On February 24, 2026, the Court in Case No. 1:23-cv-10861 (D. Mass.) granted Amgen’s motions for summary judgment of invalidity of the claims ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Zoetis (ZTS) looks undervalued: 17.3x forward P/E, $150 target with 25% upside, plus dividends/buybacks—see key risks and ...

Rice University bioengineer Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over ...

Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat ...

The political and scientific fight over the COVID vaccines rages on, years later, with the belated acknowledgment by the FDA there were likely a small number of children killed by the vaccine, despite ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was ...